A case of a 45-year-old construction worker with a history of intravenous drug use, homelessness, and occasional alcohol and tobacco use.

Chronic hepatitis C is a growing health problem worldwide that has attracted increased attention in recent years. Treatment with peginterferon and ribavirin combination had previously been the ...

(RTTNews) - Atea Pharmaceuticals (AVIR) on Wednesday announced the dosing of the first patient in its C-BEYOND phase 3 trial in the US and Canada. The trial will evaluate the combination of ...

Hepatitis C and opioid use disorder are both chronic but treatable conditions. Yet many Americans living with this deadly combination aren’t offered treatment. Imagine going to your doctor with strep ...

Whether hepatitis resolves depends on the type and whether a person receives treatment. Hepatitis A usually resolves without medications, and while sometimes hepatitis B and C may last only a few ...

Adapted with permission from [44]. Null response HCV RNA decline <2 log 10 IU/ml from baseline at week 12 Partial response HCV RNA decline >2 log 10 IU/ml from baseline at week 12, but HCV RNA ...